Search research articles
Contact Us
Filters
Showing results (131-140 of 145) with videos related to
Page
of 15
Sort By:
International Journal of Cancer
|
August 4, 1998
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
T M Behr, S Memtsoudis, R M Sharkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen
M Juweid, R M Sharkey, T Behr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies
T M Behr, B Wörmann, M Gramatzki, et al.
Cancer Research
|
February 1, 1990
Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc
D M Goldenberg, H Goldenberg, R M Sharkey, et al.
Cancer
|
December 24, 1997
Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry
T M Behr, R M Sharkey, G Sgouros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters
T M Behr, G Sgouros, M G Stabin, et al.
Cancer Research
|
September 1, 1995
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives
T M Behr, R M Sharkey, M E Juweid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1993
Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments
D M Goldenberg, T J Wlodkowski, R M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1997
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG
T M Behr, R M Sharkey, M E Juweid, et al.
Cancer Immunology, Immunotherapy : CII
|
May 1, 1997
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22
R M Sharkey, T M Behr, M J Mattes, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 145) with videos related to
Sort By:
Page
of 15
International Journal of Cancer
|
August 4, 1998
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
T M Behr, S Memtsoudis, R M Sharkey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen
M Juweid, R M Sharkey, T Behr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies
T M Behr, B Wörmann, M Gramatzki, et al.
Cancer Research
|
February 1, 1990
Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc
D M Goldenberg, H Goldenberg, R M Sharkey, et al.
Cancer
|
December 24, 1997
Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry
T M Behr, R M Sharkey, G Sgouros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters
T M Behr, G Sgouros, M G Stabin, et al.
Cancer Research
|
September 1, 1995
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives
T M Behr, R M Sharkey, M E Juweid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1993
Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments
D M Goldenberg, T J Wlodkowski, R M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1997
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG
T M Behr, R M Sharkey, M E Juweid, et al.
Cancer Immunology, Immunotherapy : CII
|
May 1, 1997
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22
R M Sharkey, T M Behr, M J Mattes, et al.
Page
of 15